Julia Calzada-Wack Selected Research

Julia Calzada-Wack Research Topics

Disease

9	Neoplasms (Cancer) 11/2022 - 05/2002
2	Cakut 12/2023 - 03/2023
2	Methylmalonic acidemia 01/2023 - 01/2020
2	Kidney Diseases (Kidney Disease) 01/2022 - 08/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 12/2021
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2017 - 01/2013
2	Male Infertility (Male Sterility) 01/2016 - 05/2011
2	Inflammation (Inflammations) 08/2011 - 05/2011
2	Lymphoma (Lymphomas) 04/2007 - 04/2003
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022
1	Polycythemia (Erythrocytosis) 11/2022
1	Adenocarcinoma 01/2022
1	Vision Disorders (Hemeralopia) 10/2021
1	Nervous System Diseases (Neurological Disorders) 10/2021
1	Gynecomastia 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Hemolytic Anemia 01/2019
1	Proteostasis Deficiencies 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Hyperphagia (Overeating) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Heart Diseases (Heart Disease) 10/2016
1	Ischemia 08/2015
1	Hypothermia 08/2015
1	Medulloblastoma 05/2015
1	Bone Resorption 10/2014
1	Anemia 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 08/2013
1	Hypophosphatemia 08/2013
1	Osteolysis 01/2013
1	Metabolic Bone Diseases (Osteopenia) 08/2012
1	Hyperplasia 01/2012
1	Adenoma (Adenomas) 01/2012
1	Cardiotoxicity 08/2011
1	Arthritis (Polyarthritis) 05/2011
1	Pheochromocytoma 05/2010
1	Leukemia 04/2007
1	Hematologic Neoplasms (Hematological Malignancy) 04/2007
1	Multiple Myeloma 05/2003
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2003
3	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 11/2022 - 05/2011
2	Transcription Factors (Transcription Factor)IBA 12/2023 - 03/2023
2	Methylmalonyl-CoA MutaseIBA 01/2023 - 01/2020
2	IronIBA 10/2021 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 05/2010
2	Cyclin D1IBA 05/2003 - 04/2003
1	Imatinib Mesylate (Gleevec)FDA Link 11/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2022
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 11/2022
1	Exonucleases (3' 5' Exonuclease)IBA 01/2022
1	exodeoxyribonuclease IIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	ProteomeIBA 01/2022
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 12/2021
1	Estrogens (Estrogen)FDA Link 10/2020
1	AndrogensIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	MethyltransferasesIBA 01/2020
1	Transfer RNA (tRNA)IBA 01/2020
1	EnzymesIBA 01/2019
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 01/2019
1	Urea (Carbamide)FDA LinkGeneric 08/2017
1	Metalloproteases (Metalloproteinases)IBA 01/2017
1	Tartrate-Resistant Acid PhosphataseIBA 01/2017
1	LipidsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2016
1	SphingolipidsIBA 01/2016
1	GangliosidesIBA 01/2016
1	Oncogene Proteins (Oncogene Protein)IBA 01/2016
1	Cardioplegic SolutionsIBA 08/2015
1	Sirtuin 1IBA 05/2015
1	MicroRNAs (MicroRNA)IBA 05/2015
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2014
1	Hormones (Hormone)IBA 10/2014
1	Pharmacologic ActionsIBA 10/2014
1	Alkaline PhosphataseIBA 08/2013
1	CollagenIBA 08/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Parathyroid Hormone-Related ProteinIBA 01/2013
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 08/2012
1	Phospholipases (Phospholipase)IBA 05/2011
1	ParaffinIBA 04/2007
1	AntibodiesIBA 04/2007
1	Formaldehyde (Formol)FDA Link 04/2007
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2003
1	Apoptosis Regulatory ProteinsIBA 05/2003
1	Cyclin-Dependent Kinase Inhibitor p27IBA 04/2003
1	Messenger RNA (mRNA)IBA 05/2002

Therapy/Procedure

3	Therapeutics 11/2022 - 11/2004